205 related articles for article (PubMed ID: 36880380)
1. Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.
Sucharov CC; Neltner B; Pietra AE; Karimpour-Fard A; Patel J; Ho CY; Miyamoto SD
Circ Heart Fail; 2023 Jun; 16(6):e010291. PubMed ID: 36880380
[TBL] [Abstract][Full Text] [Related]
2. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
3. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
[TBL] [Abstract][Full Text] [Related]
4. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
Ho CY
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
Topriceanu CC; Pereira AC; Moon JC; Captur G; Ho CY
Circulation; 2024 Jan; 149(2):107-123. PubMed ID: 37929589
[TBL] [Abstract][Full Text] [Related]
6. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.
Groarke JD; Galazka PZ; Cirino AL; Lakdawala NK; Thune JJ; Bundgaard H; Orav EJ; Levine RA; Ho CY
Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1109-1116. PubMed ID: 30052928
[TBL] [Abstract][Full Text] [Related]
8. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease.
Topriceanu CC; Moon JC; Axelsson Raja A; Captur G; Ho CY
Circ Genom Precis Med; 2024 Jun; ():e004580. PubMed ID: 38910555
[TBL] [Abstract][Full Text] [Related]
10. [The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters].
Pisklova MV; Baulina NM; Kiselev IS; Zateyshchikov DA; Favorova OO; Chumakova OS
Ter Arkh; 2023 May; 95(4):302-308. PubMed ID: 38158977
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Vissing CR; Axelsson Raja A; Day SM; Russell MW; Zahka K; Lever HM; Pereira AC; Colan SD; Margossian R; Murphy AM; Canter C; Bach RG; Wheeler MT; Rossano JW; Owens AT; Benson L; Mestroni L; Taylor MRG; Patel AR; Wilmot I; Thrush P; Soslow JH; Becker JR; Seidman CE; Lakdawala NK; Cirino AL; McMurray JJV; MacRae CA; Solomon SD; Bundgaard H; Orav EJ; Ho CY;
JAMA Cardiol; 2023 Nov; 8(11):1083-1088. PubMed ID: 37672268
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
de Marvao A; McGurk KA; Zheng SL; Thanaj M; Bai W; Duan J; Biffi C; Mazzarotto F; Statton B; Dawes TJW; Savioli N; Halliday BP; Xu X; Buchan RJ; Baksi AJ; Quinlan M; Tokarczuk P; Tayal U; Francis C; Whiffin N; Theotokis PI; Zhang X; Jang M; Berry A; Pantazis A; Barton PJR; Rueckert D; Prasad SK; Walsh R; Ho CY; Cook SA; Ware JS; O'Regan DP
J Am Coll Cardiol; 2021 Sep; 78(11):1097-1110. PubMed ID: 34503678
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.
Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K
Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
[TBL] [Abstract][Full Text] [Related]
18. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.
Guo L; Cai Y; Wang B; Zhang F; Zhao H; Liu L; Tao L
Eur J Med Res; 2023 Jun; 28(1):205. PubMed ID: 37391825
[TBL] [Abstract][Full Text] [Related]
20. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
de Feria AE; Kott AE; Becker JR
Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
